FNDR does not disburse the funds. However, it will receive funds as grant-in-aid from donors, subject to FCRA Prior Approval . FNDR shall use these funds to finance its research in pursuit of its goal of discovering therapies for the discovery of remedies of neglected diseases.
In the years 2015 – 2018, FNDR will complete fitting-out its leased facility to start with malaria and tuberculosis research programs. Thereafter, FNDR will initiate work on standardization and validation of various in vitro drug screening platforms and animal models of tuberculosis and malaria followed by chemistry work to support lead optimization programs.
|Name of Donor||Amount||Date of Receipt||FCRA BANK ACCOUNT NUMBER||Purpose of Receipt||Mode and Purpose of Utilization||Additional Remarks|
|Astra Zeneca AB||INR 3,38,50,000|
|06/01/2017||50200008168382||P1303 - Donations to religious and charitable institutions in india||Research Activity||NA|
|Astra Zeneca AB||INR 3,17,00,000
|10/08/2017||50200008168382||P1303 - Donations to religious and charitable institutions in india||Research Activity||NA|
Annual reports of FNDR for Financial years 2014, 2015 and 2016.